Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration-Reference-Cited by-同舟云学术

Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration

Author:

Gatwood Katie S.¹^ORCID,Dholaria Bhagirathbhai R.²^ORCID,Lucena Mariana³,Baer Brittney⁴,Savani Bipin N.²⁵,Oluwole Olalekan O.²^ORCID

Affiliation:

1. Department of Pharmacy Vanderbilt University Medical Center Nashville Tennessee USA

2. Division of Hematology‐Oncology Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

3. Medexus Pharmaceuticals, Inc. Chicago Illinois USA

4. Department of Nursing Clinical Trials Office Vanderbilt University Medical Center Nashville Tennessee USA

5. Division of Hematology‐Oncology Department of Medicine Tennessee Valley Healthcare System Nashville Tennessee USA

Publisher

Wiley

Link

Reference24 articles.

2. Tisagenlecleucel in adult relapsed or refractory diffuse large B‐cell lymphoma;Schuster SJ;N Engl J Med,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献